Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia ; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia.
PLoS One. 2013 Sep 27;8(9):e76218. doi: 10.1371/journal.pone.0076218. eCollection 2013.
Pathways coordinated by innate pattern recognition receptors like mannose-binding lectin (MBL) and nucleotide-binding oligomerization domain 2 (NOD2) are among the first immune responses to Staphylococcus aureus (S. aureus) bloodstream infections (BSI) in animal models, but human data are limited. Here, we investigated the role of MBL deficiency and NOD2 mutations in the predisposition to and severity of S. aureus BSI.
A matched case-control study was undertaken involving 70 patients with S. aureus BSI and 70 age- and sex-matched hospitalized controls. MBL levels, MBL2 and NOD2 polymorphisms were analyzed.
After adjusting for potential confounders, MBL deficiency (<0.5 µg/ml) was found less frequently in cases than controls (26 vs. 41%, OR 0.4, 95% confidence interval (CI) 0.20-0.95, p=0.04) as were low producing MBL genotypes (11 vs. 23%, OR 0.2, 95% CI 0.08-0.75, p=0.01), whereas NOD2 polymorphisms were similarly distributed. Cases with NOD2 polymorphisms had less organ dysfunction as shown by a lower SOFA score (median 2.5 vs. 4.5, p=0.02), whereas only severe MBL deficiency (<0.1 µg/ml) was associated with life-threatening S. aureus BSI (OR 5.6, 95% CI 1.25-24.85, p=0.02).
Contrary to animal model data, our study suggests MBL deficiency may confer protection against acquiring S. aureus BSI. NOD2 mutations were less frequently associated with multi-organ dysfunction. Further human studies of the innate immune response in S. aureus BSI are needed to identify suitable host targets in sepsis treatment.
先天模式识别受体(如甘露糖结合凝集素(MBL)和核苷酸结合寡聚化结构域 2(NOD2))协调的途径是动物模型中金黄色葡萄球菌(S. aureus)血流感染(BSI)的最初免疫反应之一,但人类数据有限。在这里,我们研究了 MBL 缺乏和 NOD2 突变在金黄色葡萄球菌 BSI 的易感性和严重程度中的作用。
进行了一项匹配的病例对照研究,涉及 70 例金黄色葡萄球菌 BSI 患者和 70 名年龄和性别匹配的住院对照。分析了 MBL 水平、MBL2 和 NOD2 多态性。
调整潜在混杂因素后,病例组中 MBL 缺乏(<0.5 µg/ml)的频率低于对照组(26%比 41%,OR 0.4,95%置信区间(CI)0.20-0.95,p=0.04),低产 MBL 基因型的频率也较低(11%比 23%,OR 0.2,95%CI 0.08-0.75,p=0.01),而 NOD2 多态性的分布相似。NOD2 多态性的病例器官功能障碍程度较低,SOFA 评分中位数为 2.5(比 4.5,p=0.02),而只有严重的 MBL 缺乏(<0.1 µg/ml)与金黄色葡萄球菌 BSI 的威胁生命有关(OR 5.6,95%CI 1.25-24.85,p=0.02)。
与动物模型数据相反,我们的研究表明 MBL 缺乏可能对金黄色葡萄球菌 BSI 的发生具有保护作用。NOD2 突变与多器官功能障碍的相关性较小。需要进一步进行金黄色葡萄球菌 BSI 中先天免疫反应的人体研究,以确定脓毒症治疗中的合适宿主靶点。